Chih-Yi Liao to Receptors, Peptide
This is a "connection" page, showing publications Chih-Yi Liao has written about Receptors, Peptide.
Connection Strength
0.917
-
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).
Score: 0.863
-
Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2025 01; 177:108834.
Score: 0.054